This section includes information and resources about Diabetes for journalists: Boehringer Ingelheim press releases, background information, related press kits and a collection of images and videos.
| 17.11.2011 |
Boehringer Ingelheim race to the finish line in support of World Diabetes Day - EX US and UK. |
|---|---|
| 16.09.2011 |
New data for once-daily linagliptin show durable efficacy over two years - For Medical Media outside the US and UK only. |
| 13.09.2011 |
Boehringer Ingelheim and EFSD collaborate to support diabetes research in Europe - For NON-UK and NON-US / Medical Media only. |
| 25.08.2011 |
Trajenta® (linagliptin) receives approval for the treatment of type 2 diabetes in Europe - EX US and UK / Medical Media Only. |
| 27.06.2011 |
New data for linagliptin* show clinically meaningful efficacy similar to glimepiride but with fewer cardiovascular events - EX US and UK. Medical Media Only. |
Diabetes Related News Room